Published in J Stroke Cerebrovasc Dis on January 14, 2011
Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment. J Am Geriatr Soc (2013) 2.11
Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med (2015) 1.74
HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study. Mol Psychiatry (2014) 0.95
Statins, cognition, and dementia—systematic review and methodological commentary. Nat Rev Neurol (2015) 0.85
Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease. Neurobiol Aging (2014) 0.84
Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci (2014) 0.83
Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease. Lipids Health Dis (2012) 0.83
Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors. Front Aging Neurosci (2014) 0.80
Alzheimer disease: statins in the treatment of Alzheimer disease. Nat Rev Neurol (2011) 0.80
Physical activity, cognitive function, and brain health: what is the role of exercise training in the prevention of dementia? Brain Sci (2012) 0.80
Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage. Acta Pharmacol Sin (2015) 0.79
Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study. Medicine (Baltimore) (2015) 0.78
Statins and brain integrity in older adults: Secondary analysis of the Health ABC study. Alzheimers Dement (2015) 0.77
Cholesterol, statins, and dementia: what the cardiologist should know. Clin Cardiol (2015) 0.76
Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis (2015) 0.76
Overcoming Challenges With Statin Therapy. J Am Heart Assoc (2016) 0.76
Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans. Ethn Dis (2015) 0.76
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. Alzheimers Res Ther (2017) 0.75
Blood cholesterol in late-life and cognitive decline: a longitudinal study of the Chinese elderly. Mol Neurodegener (2017) 0.75
The Effect of Statins on Rate of Cognitive Decline in Mild Cognitive Impairment. Alzheimers Dement (N Y) (2017) 0.75
The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration. Metab Brain Dis (2017) 0.75
Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors. J Clin Med Res (2017) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA (2001) 9.16
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol (2000) 8.07
Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology (2010) 3.58
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology (2008) 2.97
Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology (2004) 2.83
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72
Pravastatin therapy and the risk of stroke. N Engl J Med (2000) 2.46
The dementias. Lancet (2002) 2.42
Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol (2002) 2.18
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol (2004) 2.09
A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis (2001) 2.07
Cardiovascular disease risk factors and cognitive impairment. Am J Cardiol (2006) 1.91
The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials (2006) 1.88
Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol (2009) 1.86
Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry (2005) 1.78
Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76
The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol (2007) 1.73
Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem (2005) 1.52
Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology (2005) 1.43
Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA (1999) 1.42
Statins reduce amyloid-beta production through inhibition of protein isoprenylation. J Biol Chem (2007) 1.38
Using telephone and informant assessments to estimate missing Modified Mini-Mental State Exam scores and rates of cognitive decline. The cardiovascular health study. Neuroepidemiology (2009) 1.33
Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology (2004) 1.27
Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol (2006) 1.19
Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study. J Am Geriatr Soc (2002) 1.11
Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Am J Cardiol (2003) 1.07
Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology (2002) 1.04
Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects. Pharmacol Ther (2006) 1.01
Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease. J Lipid Res (2003) 1.00
Epidemiology of dementia: concepts and overview. Neurol Clin (2000) 0.99
Statin therapy in the treatment of Alzheimer disease: what is the rationale? Am J Med (2005) 0.87
Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA (2010) 8.90
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA (2012) 6.29
Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00
Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation (2007) 5.87
Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med (2008) 5.86
Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation (2009) 5.26
The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol (2008) 5.05
Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2007) 3.90
Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet (2002) 3.88
Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med (2008) 3.76
Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66
Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc (2004) 3.52
Thyroid status, cardiovascular risk, and mortality in older adults. JAMA (2006) 3.50
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2004) 3.26
A social model for health promotion for an aging population: initial evidence on the Experience Corps model. J Urban Health (2004) 3.18
NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet (2009) 3.18
Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med (2010) 3.05
Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation (2007) 2.93
The association of pericardial fat with calcified coronary plaque. Obesity (Silver Spring) (2008) 2.93
Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation (2003) 2.88
Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med (2009) 2.82
Fish intake and risk of incident atrial fibrillation. Circulation (2004) 2.82
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg (2002) 2.69
The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging (2010) 2.69
Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology (2013) 2.61
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA (2009) 2.59
Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation (2006) 2.57
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation (2009) 2.55
White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke (2004) 2.50
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation (2005) 2.48
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47
The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2008) 2.43
Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults. J Am Geriatr Soc (2005) 2.31
Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air). Am J Epidemiol (2012) 2.23
The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2010) 2.15
Associations of gait speed and other measures of physical function with cognition in a healthy cohort of elderly persons. J Gerontol A Biol Sci Med Sci (2007) 2.14
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berl) (2004) 2.07
Experience Corps: design of an intergenerational program to boost social capital and promote the health of an aging society. J Urban Health (2004) 2.04
"Successful aging": effect of subclinical cardiovascular disease. Arch Intern Med (2003) 2.02
Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2011) 2.01
Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke (2005) 2.00
Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care (2004) 1.99
Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (2006) 1.97
Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis (2008) 1.96
Alcohol use and risk of ischemic stroke among older adults: the cardiovascular health study. Stroke (2005) 1.94
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
Incidence of cardiovascular disease in older Americans: the cardiovascular health study. J Am Geriatr Soc (2005) 1.90
White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study. Neurobiol Aging (2006) 1.88
The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials (2006) 1.88
The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort. J Clin Endocrinol Metab (2004) 1.84
Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the cardiovascular health study). Am J Cardiol (2005) 1.82
Training and maintaining memory abilities in healthy older adults: traditional and novel approaches. J Gerontol B Psychol Sci Soc Sci (2007) 1.81
Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care (2010) 1.80
Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76
Modeled cost-effectiveness of the Experience Corps Baltimore based on a pilot randomized trial. J Urban Health (2004) 1.76
Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab (2012) 1.75
Short-term impact of Experience Corps participation on children and schools: results from a pilot randomized trial. J Urban Health (2004) 1.75
Fish intake and risk of incident heart failure. J Am Coll Cardiol (2005) 1.74
Anemia and 9-year domain-specific cognitive decline in community-dwelling older women: The Women's Health and Aging Study II. J Am Geriatr Soc (2009) 1.73
Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology (2013) 1.71
The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc (2013) 1.71
In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol (2002) 1.70
A priori-defined dietary patterns and markers of cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2008) 1.68
A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. J Gerontol A Biol Sci Med Sci (2010) 1.65
Dietary patterns and incident cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr (2009) 1.62
Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. Arch Intern Med (2002) 1.61
Left ventricular global function index by magnetic resonance imaging--a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension (2013) 1.61
Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Arch Intern Med (2002) 1.56
Relationship between coronary artery calcification and other measures of subclinical cardiovascular disease in older adults. Arterioscler Thromb Vasc Biol (2002) 1.55
Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension (2011) 1.54
Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. Biol Psychiatry (2008) 1.54
Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA (2003) 1.54
Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr (2008) 1.54
The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. J Pharmacol Exp Ther (2007) 1.53
Total and cause-specific mortality in the cardiovascular health study. J Gerontol A Biol Sci Med Sci (2009) 1.53
Low-risk lifestyle, coronary calcium, cardiovascular events, and mortality: results from MESA. Am J Epidemiol (2013) 1.52
Detection of septal coronary collaterals by color flow Doppler mapping is a marker for anomalous origin of a coronary artery from the pulmonary artery. J Am Soc Echocardiogr (2002) 1.52
The aging and dying processes and the health of older adults. J Clin Epidemiol (2002) 1.51
Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis (2005) 1.50
Impaired vision and the ability to take medications. J Am Geriatr Soc (2005) 1.49
Soap operas and talk shows on television are associated with poorer cognition in older women. South Med J (2006) 1.49
Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study. Circ Cardiovasc Qual Outcomes (2009) 1.48